HBP Surgery Week 2025

Program

  • March 27 (Thu)
  • March 28 (Fri)
  • March 29 (Sat)
08:30-10:00
Liver Symposium 1 - Considerations for improving the oncologic outcomes of IHCC
[Modreator(s)] Yang Won NAH (Korea), Rawisak CHANWAT (Thailand)
08:30-08:50
LN metastasis prediction for IHCC on preoperative images
Hyungjin RHEE (Korea)
08:50-09:10
The role of neoadjuvant chemotherapy for IHCC
Jeesun YOON (Korea)
09:10-09:30
Optimal extent of liver resection and LN dissection for IHCC
Etsuro HATANO (Japan)
09:30-09:50
Optimal indication of liver transplantation for IHCC
Dong Jin JOO (Korea)
09:50-10:00
Discussion
08:30-10:00
BP Symposium 1 - Neuroendocrine tumor of the pancreas: what is new?
[Modreator(s)] Sung Sik HAN (Korea), Masafumi NAKAMURA (Japan)
08:30-08:50
Pancreatic neuroendocrine tumors: diagnosis and pitfalls
Jae Hee CHO (Korea)
08:50-09:10
Lymph node dissection for non-functional pancreas neuroendocrine neoplasm: is it worthwhile?
Sho KIRITANI (Japan)
09:10-09:30
Systemic treatment of advanced pancreatic neuroendocrine tumors
Jin Young KIM (Korea)
09:30-09:50
Incidentally found small pNET: observation vs resection?
Hye-Sol JUNG (Korea)
09:50-10:00
Discussion
08:30-10:00
Liver Beginners' Clinic - Comprehensive guide to minimally invasive liver resection
[Modreator(s)] Young Mok PARK (Korea), Chan Woo CHO (Korea)
08:30-08:50
Essential anatomy for liver resection
Youngil CHOI (Korea)
08:50-09:10
Technical tips & tricks of intraoperative ICG & US
YoungRok CHOI (Korea)
09:10-09:30
Step by step: MIS of major liver resection
Woohyung LEE (Korea)
09:30-09:50
Step by step: MIS of parenchymal sparing liver resection depending on tumor location
Young Seok HAN (Korea)
09:50-10:00
Discussion
08:30-10:00
Basic Research Session 1 - Cutting edge technique of research for HBP surgeon
[Modreator(s)] Young Dong YU (Korea), Seokhwan KIM (Korea)
08:30-08:50
Microbiome research for HBP surgeon
Kwang-Woong LEE (Korea)
08:50-09:10
Car-T research for HBP Surgeon
Jung Yong HONG (Korea)
09:10-09:30
Exosome research for HBP surgeon
Ssang-Goo CHO (Korea)
09:30-09:50
Spatial genomics for HBP surgeon
Jong-Eun PARK (Korea)
09:50-10:00
Discussion
08:30-10:00
Meeting of Asian HBP Societies - HBP Surgery in Asia
[Modreator(s)] Ki-Hun KIM (Korea), Jai Young CHO (Korea)
08:30-08:45
Liver transplantation in Singapore
Glenn Kunnath BONNEY (Singapore)
08:45-09:00
HBP surgery in Thailand and the introduction of A-PHPBA 2025 in Bangkok
Anon CHOTIROSNIRAMIT (Thailand)
09:00-09:15
Liver transplantation in Vietnam
Le Van THANH (Vietnam)
09:15-09:30
Minimal invasive HBP surgery in Malaysia
Peng Soon KOH (Malaysia)
09:30-09:45
Nontechnical skill training in HPB surgery: Indonesian experience
Adianto NUGROHO (Indonesia)
09:45-10:00
Discussion
10:00-10:20
Opening Ceremony
10:20-10:50
Liver Invited Lecture 1 - Peri-operative PVT management in liver transplant recipients
[Modreator(s)] Hee Chul YU (Korea)
10:20-10:50
Peri-operative PVT management in liver transplant recipients
Edward Wolfgang LEE (USA)
10:20-10:50
BP Invited Lecture 1 - DPPHR for cystic neoplasms of the pancreatic head: the balance between the clinical meaning and the morbidity
[Modreator(s)] Kyung Sik KIM (Korea)
10:20-10:50
DPPHR for cystic neoplasms of the pancreatic head: the balance between the clinical meaning and the morbidity
Hans G. BEGER (Germany)
10:20-11:50
KAHBPS Fund Study
[Modreator(s)] Dongho CHOI (Korea), Young Seok HAN (Korea)
10:20-10:25
면역결핍 인간화 간 마우스모델 시스템 구축 및 차세대 항암연구
(Immune deficient humanized liver mouse model system construction and next-generation anticancer research)
Eunyoung Tak (Korea)
10:25-10:30
복강경 기증자 간절제술 시대에 생존 기증자 간 이식 후 담도 합병증 없는 생존을 위한 위험 요소 분석 및 예측 모델 구축
(Predictive model for biliary complication after living donor liver transplantation in the era of laparoscopic donor hepatectomy)
Seo Young HONG (Korea)
10:30-10:35
T2 담낭암의 임상적 난제 해결을 위한 국내 다기관 연구
(A multicenter study to solve current unsolved issues for T2 gallbladder cancer)
Woohyung LEE (Korea)
10:35-10:40
개복, 복강경과 로봇 췌십이지장절제술 후 임상적 결과에 대한 네트워크 메타분석을 이용한 비교
(Indirect comparison of perioperative outcomes between open, laparoscopic, and robotic pancreaticoduodenectomy: systemic review and network meta-analysis)
Woohyung LEE (Korea)
10:40-10:45
성별에 따른 복강경 에너지 기구 조작 능력에 대한 정량적 분석: 인간공학적 연구
(Sex-related Disparities in Laparoscopic Surgery: Ergonomic Insights and Performance Variations)
Hye-Sol JUNG (Korea)
10:45-10:50
생체간이식 환자에서 인도시아닌 형광영상을 이용한, 담도합병증 예측모델
(Biliary complication prediction model using ICG flurorescence imaging in living donor liver transplantation)
Jaewon LEE (Korea)
10:50-10:55
췌장 체적 측정을 이용한 췌십이지장 절제술 이후 발생하는 췌장의 내분비 기능 이상 위험인자 평가
(Assessment of risk factor for pancreatic endocrine insufficiency using the pancreas volumetry in patients underwent pancreaticoduodenectomy)
Dooho LEE (Korea)
10:55-11:02
오가노이드를 활용한 담도암 조기 진단 모델 개발
(Development of early diagnostic model for biliary tract cancer using organoids)
Seokhwan KIM (Korea)
11:02-11:09
고령의 고위험 췌담도계암 수술 환자에 대한 사전 재활의 임상적 적용을 위한 효율적인 평가 및 적용 프로토콜의 개발: 예비연구
(Development of an efficient assessment and implementation protocol for prehabilitation in high-risk elderly patients undergoing surgery for pancreatico-biliary cancer: a pilot study)
Hyeong Min PARK (Korea)
11:09-11:16
대사이상 지방 간염 (MASH) 마우스를 이용한 간절제술 모델 개발 및 간재생과 관련된 경로 규명
(Development of partial hepatectomy model in metabolic dysfunction-associated steatohepatitis (MASH) mouse and identification of liver regeneration associated pathway)
Na Reum KIM (Korea)
11:16-11:23
딥러닝을 이용한 선행항암화학 요법 후 근치적 절제술을 시행한 췌장암환자의 예후 예측 모델
(Prognostic predictive model of curative resection after neoadjuvant chemotherapy in pancreatic cancer patients using deep learning)
Mirang LEE (Korea)
11:23-11:30
복강내 배액관의 RGB 색상 감지를 이용한 수술 후 합병증 예측 모델 개발
(Development of a Postoperative Complication Prediction Model Using RGB Sensors on Intra-abdominal Drainage Tubes)
So Jeong YOON (Korea)
11:30-11:37
T1b 담낭암에서의 단순 담낭절제술과 광범위 담낭절제술의 효과 비교 : 메타분석
(Simple cholecystectomy versus extended cholecystectomy in T1b gallbladder cancer: meta-analysis)
In Soo CHO (Korea)
10:20-11:50
간세포암에 대한 다양한 치료 전략의 효능 비교: 네트워크 메타분석
(Comparison of efficacy of various treatment strategies for hepatocellular carcinoma: A network meta-analysis)
Sang Hoon KIM (Korea)
10:50-11:50
Liver Meet the Professor 1 - How did I start my robotic liver resection program?
[Modreator(s)] Sang Jin KIM (Korea)
10:50-11:00
How did I start my robotic liver resection program? - Taiwan
Yao-Ming WU (Taiwan)
11:00-11:10
How did I start my robotic liver resection program? - Korea
Gi Hong CHOI (Korea)
11:10-11:20
How did I start my robotic liver resection program? - Japan
Yutaro KATO (Japan)
11:20-11:50
Discussion
10:50-11:50
BP Meet the Professor 1 - Minimally invasive pancreatoduodenectomy: an open surgeon’s perspective
[Modreator(s)] Jun Suh LEE (Korea)
10:50-11:00
Case Presentation – resection phase
Jaewoo KWON (Korea)
11:00-11:10
Case Discussions with Invited Professors
11:10-11:20
Case Presentation – reconstruction phase
Munseok CHOI (Korea)
11:20-11:30
Case Discussions with Invited Professors
11:30-11:40
Master's advice on MIPD
Koo Jeong KANG (Korea)
11:40-11:50
Master's advice on MIPD
Hiroki YAMAUE (Japan)
10:50-11:50
Basic Research Oral Presentation
[Modreator(s)] Je Ho RYU (Korea), Ho Kyoung HWANG (Korea)
10:50-10:57
GENOMIC BIOMARKERS TO PREDICT RESPONSE TO COMBINATION IMMUNOTHERAPY IN HEPATOCELLULAR CARCINOMA
Sung Hwan LEE (Korea)
10:57-11:04
GENOMIC ANALYSIS OF COMBINED HEPATOCELLULAR-CHOLANGIOCARCINOMA REVEALS COMMON LINEAGE OF TUMOR COMPONENTS WITH UNIQUE GENE EXPRESSION PROFILE
Yeshong PARK (Korea)
11:11-11:18
DEVELOPMENT AND OPTIMIZATION OF TRANSPLANT SURGEON-INNOVATED EVMP: VALIDATION IN A PORCINE DCD LIVER TRANSPLANT MODEL
Munseok CHOI (Korea)
11:18-11:25
DEVELOPMENT OF IMMUNE-EVASIVE META-SOFT ORGAN MODULES THROUGH ADVANCED CELL ENGINEERING AND ASSEMBLY TECHNOLOGY
Chae Eun LEE (Korea)
11:25-11:32
DEVELOPMENT OF A COLLAGEN-PERIOSTIN BASED DRUG EVALUATION PLATFORM USING PATIENT-DERIVED PANCREATIC CANCER ORGANOIDS
Min Kyu SUNG (Korea)
11:32-11:39
THERAPEUTIC POTENTIAL OF EXOSOMES FROM HUMAN CHEMICALLY DERIVED HEPATIC PROGENITOR CELLS (HCDHS) IN LIVER DAMAGE
A-Reum KIM (Korea)
11:39-11:48
DEVELOPMENT AND VALIDATION OF A NOVEL DIGITAL PCR ASSAY TARGETING CIRCULATING TUMOR DNA METHYLATION BIOMARKERS FOR HEPATOCELLULAR CARCINOMA SCREENING.
Sun Jae PARK (Korea)
11:50-12:00
Break
12:00-13:00
Luncheon Symposium 1
[Modreator(s)] Ki-Hun KIM (Korea)
12:00-13:00
The first & only HCC adjuvant cell-therapy (Immuncell-LC): 9-year extended follow-up
Hye Won LEE (Korea)
13:00-13:20
Chairman Lecture
[Modreator(s)] Jin-Young JANG (Korea)
13:00-13:20
My HBP surgery 
Ki-Hun KIM (Korea)
13:00-13:20
Liver Invited Lecture 2 - The challenge of pre-transplant immunotherapy and post-transplant immunosuppression
[Modreator(s)] Hwon Kyum PARK (Korea)
12:00-13:00
The challenge of pre-transplant immunotherapy and post-transplant immunosuppression
Vincenzo MAZZAFERRO (Italy)
13:20-13:50
BP Invited Lecture 2 - Translational research in pancreatic cancer surgery
[Modreator(s)] Dongho CHOI (Korea)
13:20-13:50
Translational research in pancreatic cancer surgery
Joon Seong PARK (Korea)
13:20-14:40
Korea-Japan Educational Collaboration Meeting for young HBP surgeons - Challenges facing HBP surgeons in Korea and Japan: a contemporary crisis
[Modreator(s)] Jeong-Ik PARK (Korea), Takanobu HARA (Japan)
13:20-13:30
Next generation project in Japan
Hiroko OKINAGA (Japan)
13:30-13:40
Results of questionnaire survey
Tomoaki YOH (Japan)
13:40-14:00
Current crisis in (HBP) surgeons in Korea
Yoon Bin JUNG (Korea)
14:00-14:35
Panel discussion: recruitment-education
Seokhwan KIM (Korea), Yeongsoo JO (Korea), Boram LEE (Korea), Yoo Jin CHOI (Korea), Tomoaki YOH (Japan), Norihiro ISHII (Japan), Yasuko MATSUO (Japan), Aya MAEKAWA (Japan), Saori UMEZAWA (Japan), Yukiko KOSAI (Japan)
14:35-14:40
Closing remark
[Modreator(s)] Susumu EGUCHI (Japan)
13:20-14:40
Medical Insurance Policy - 간담췌외과의 보험 정책 (Insurance policies in hepatobiliary and pancreatic surgery)
[Modreator(s)] Jin Hong LIM (Korea)
13:20-13:40
보험 수가 결정 체계 (National health insurance fee determination system)
Minho SHIN (Korea)
13:40-14:00
간절제술의 수가 세분화 (Subdivision of insurance fee for liver surgery)
Bo-Hyun JUNG (Korea)
14:00-14:20
췌담도 절제술의 림프절 절제술 세분화 (Subdivision of insurance fee for lymph node dissection in pancreatobiliary surgery)
Min Kyu SUNG (Korea)
14:20-14:40
보험위원회의 역할과 앞으로 나아갈 방향 (Role of the insurance committee and future directions)
Jin Hong LIM (Korea)
13:50-14:50
Liver Debate 1 - Is the external bile duct stent insertion worth enough in LDLT?
[Modreator(s)] Nam Kyu CHOI (Korea), Kwang-Woong LEE (Korea)
13:50-14:05
Favor
Dong-Hwan JUNG (Korea)
14:05-14:20
"Against (*Special Comment: The Introduction of ILTS 2025) Against (*Special Comment: Introduction of ILTS 2025)"
Alfred Wei Chieh KOW (Singapore)
14:20-14:50
Discussion (+ Voting)
14:50-15:30
Poster Presentation 1
[Modreator(s)] YoungRok CHOI (Korea), JaRyung HAN (Korea)
14:50-14:55
TEN YEAR EFFICACY: THE ENDURING ROLE OF AFP AND PIVKA-II IN HCC AFTER LIVING DONOR LIVER TRANSPLANTATION
Saran Ochir GONGOR (Korea)
14:55-15:00
OUTCOMES OF LIVER TRANSPLANTATION FROM EXTENDED BRAIN-DEAD DONOR
Dang DO HAI (Vietnam)
15:00-15:05
ANALYSIS OF ACLF CASES UNDERGOING INTENSIVE CARE PRIOR TO LIVER TRANSPLANTATION
Takanobu HARA (Japan)
15:05-15:10
PREVALENCE AND RISK FACTORS OF CYTOMEGALOVIRUS INFECTION IN PATIENTS AFTER LIVING DONOR LIVER TRANSPLANTATION
The Duy NGUYEN (Vietnam)
15:10-15:15
SEVERITY AND PATTERN OF BILE DUCT COMPLICATIONS AFTER DONOR RIGHT HEPATECTOMY: OPEN VERSUS MINIMALLY INVASIVE APPROACHES
Na Reum KIM (Korea)
15:15-15:20
PROPORTION OF HEPATOCELLULAR CARCINOMA PATIENT WHOM CANDIDATE FOR LIVER TRANSPLANT ELIGIBLE FOR UPFRONT LIVER TRANSPLANT: SINGLE CENTER STUDY
Pannop UEASEREEWONG (Thailand)
15:20-15:25
EARLY EXPERIENCE WITH ROBOTIC SINGLE-PORT LIVER RESECTIONS USING THE DA VINCI SP SYSTEM IN A SMALL CENTER
EUN JEONG JANG (Korea)
14:50-15:30
Poster Presentation 2
[Modreator(s)] Woohyung LEE (Korea), Suk Kyun HONG (Korea)
14:50-14:55
ONCOLOGIC OUTCOME OF MORE THAN 10 CM RESECTABLE HEPATOCELLULAR CARCINOMA
Jonathan NAVARRO (Philippines)
14:55-15:00
THE LIVER-FIRST APPROACH IN THE TREATMENT OF PATIENTS WITH BORDERLINE RESECTABLE SYNCHRONOUS COLORECTAL LIVER METASTASES: INITIAL EXPERIENCE OF A NEWLY ESTABLISHED HEPATOPANCREATOBILIARY UNIT
Sergei SIKACHOV (Ukraine)
15:00-15:05
CLINICAL OUTCOMES AND MORBIDITY ANALYSIS OF RIGHT TRISECTIONECTOMY OR EXTENED RIGHT LOBECTOMY FOR HEPATOBILIARY DISEASE
Min-ha CHOI (Korea)
15:05-15:10
ANALYSIS OF THE RESULTS OF SURGICAL TREATMENT OF BENIGN LIVER TUMORS
Farukh MAHMADZODA (Tajikistan)
15:10-15:15
MASLD IN LT PATIENTS
Sukmin GWON (Korea)
15:15-15:20
ASSESSMENT OF PSYCHOLOGICAL HEALTH IN RECIPIENTS UNDERGOING LIVER TRANSPLANTATION AND ASSOCIATED FACTORS IN VIETNAM
CAM LINH LE (Vietnam)
14:50-15:30
Poster Presentation 3
[Modreator(s)] Young-in YOON (Korea), Chan Woo CHO (Korea)
14:50-14:55
DEVELOPMENT AND VALIDATION OF A RISK STRATIFICATION MODEL FOR POST-HEPATECTOMY DISTANT METASTASIS IN HEPATOCELLULAR CARCINOMA: A MULTI-CENTER STUDY
Yuze YANG (China)
14:55-15:00
KNOWLEDGE, ATTITUDE AND WILLINGNESS OF COMMUNITY DWELLING INDIVIDUALS FOR LIVE LIVER DONOR SURGERY
Javad ALIZARGAR (Iran)
15:00-15:05
SURGICAL QUALITY ASSESSMENT WITH ARTIFICIAL INTELLIGENCE-BASED VIDEO ANALYSIS FOR LAPAROSCOPIC DONOR RIGHT HEMIHEPATECTOMY: USEFULNESS OF ROUND LIGAMENT FIXATION IN HILAR STRUCTURE DISSECTION
Dai Hoon HAN (Korea)
15:05-15:10
IMPACT OF DIRECT-ACTING ANTIVIRAL THERAPY TIMING ON HEPATOCELLULAR CARCINOMA RECURRENCE AFTER LIVER RESECTION IN HEPATITIS C PATIENTS: A MULTICENTER RETROSPECTIVE STUDY
Woo Jin CHOI (Canada)
15:10-15:15
LAPAROSCOPIC RIGHT ANTERIOR OR POSTERIOR SECTIONECTOMY FOR HCC: SURGICAL OUTOCMES BASED ON SURGEON'S LEARNING CURVE
Su Hyeong PARK (Korea)
15:15-15:20
THE IMPACT OF MULTIDISCIPLINARY TEAM APPROACH ON CLINICAL OUTCOMES IN HEPATOCELLULAR CARCINOMA: A PROPENSITY SCORE-MATCHED COHORT STUDY
Sang Hyuk PARK (Korea)
15:20-15:25
COMPARISON OF LEARNING CURVE DIFFERENCE OF LAPAROSCOPIST ACCORDING TO CONTROLLER TYPE OF FLEXIBLE SCOPE DURING LAPAROSCOPIC LIVER RESECTION
Sunghae PARK (Korea)
14:50-15:30
Poster Presentation 4
[Modreator(s)] Jeong-Ik PARK (Korea), Hongbeom KIM (Korea)
14:50-14:55
PLASMA CELL-FREE RNA ANALYSIS HIGHLIGHTS KEY MOLECULAR CHANGES IN EARLY- AND ADVANCED-STAGE PANCREATIC CANCER
Hyeong Seok KIM (Korea)
14:55-15:00
IMPACT OF CHOLELITHIASIS AND CHOLECYSTECTOMY ON THE INCIDENCE OF TYPE 2 DIABETES: LONG-TERM FOLLOW-UP OF KOREAN NATIONWIDE DATA
Naru KIM (Korea)
15:00-15:05
IMPACT OF NEOADJUVANT THERAPY ON ONCOLOGIC OUTCOMES IN RECURRENT PANCREATIC DUCTAL ADENOCARCINOMA: A MULTICENTER RETROSPECTIVE STUDY
Hyelim JOO (Korea)
15:05-15:10
CUT-SURFACE MARGIN (0MM RULE) STATUS IS STILL MEANING IN RESECTED PANCREATIC CANCER? : UPFRONT SURGERY VS NEOADJUVANT THERAPY
Yeonsu KIM (Korea)
15:10-15:15
PANCREATICODUODENECTOMY FOR METACHRONOUS PERIAMPULLARY CANCER FOLLOWING CURATIVE RESECTION OF EXTRAHEPATIC BILE DUCT CANCER
Hyung Il SEO (Korea)
15:15-15:20
“CAN WE GO MORE MINIMAL?” : COMPARATIVE STUDY OF SHORT-TERM OUTCOME OF BETWEEN SINGLE PORT (SP) AND MULTIPORT (SI/XI) ROBOTIC DISTAL PANCREATECTOMY
Sehyeon YU (Korea)
15:20-15:25
COMPARISON OF PROGNOSIS ACCORDING TO PREOPERATIVE BILIARY DRAINAGE (PTBD VERSUS ERBD) IN PATIENTS WITH RESECTED PANCREATODUODENECTOMY
JI SU KIM (Korea)
14:50-15:30
Poster Presentation 5
[Modreator(s)] Jaewoo KWON (Korea), Jae Do YANG (Korea)
14:50-14:55
EARLY RECURRENCE PREDICTORS AND PATTERNS AFTER RESECTION FOR PANCREATIC DUCTAL ADENOCARCINOMA: IS THE SURGEON ONLY A BYSTANDER?
Alex M. ROCH (USA)
14:55-15:00
TEXTBOOK OUTCOMES OF TOTALLY ROBOTIC VERSUS TOTALLY LAPAROSCOPIC PANCREATICODUODENECTOMY FOR PERIAMPULLARY NEOPLASM: A PROPENSITY SCORE MATCHED COHORT-STUDY
Seung Yeon LIM (Korea)
15:00-15:05
THE ROLE OF NEOADJUVANT CHEMOTHERAPY (NCT) IN THE TREATMENT OF PATIENTS WITH RESECTABLE PANCREATIC CANCER.
Ilya VERVEKIN (Russian Federation)
15:05-15:10
ARTIFICIAL INTELLIGENCE-POWERED SPATIAL ANALYSIS OF TUMOR-INFILTRATING LYMPHOCYTES PREDICTS PROGNOSIS IN RESECTED GALLBLADDER CANCER
So Jeong YOON (Korea)
15:10-15:15
GREAT SAPHENOUS VEIN PANEL GRAFT: A NOVEL TECHNIQUE FOR VASCULAR RESECTION AND RECONSTRUCTION AFTER PANCREATICODUODENECTOMY
Ativitch ASAVACHAISUVIKOM (Thailand)
15:15-15:20
PURE SINGLE INCISION LAPAROSCOPIC CHOLECYSTECTOMY USING AN ARTICULATING INSTRUMENT: EWHA METHOD
Yeongsoo JO (Korea)
15:20-15:25
COMPARISON OF ROBOTIC AND OPEN PANCREATICODUODENECTOMY WITH PORTAL-SUPERIOR MESENTERIC VEIN RESECTION FOR ADVANCED PERI-AMPULLARY TUMORS
PengYu KU (Taiwan)
14:50-15:30
Poster Presentation 6
[Modreator(s)] Sung Hyun KIM (Korea), Hyung Sun KIM (Korea)
14:50-14:55
COMPARATIVE CLINICAL IMPACT OF PORTAL VEIN/SUPERIOR MESENTERIC VEIN ENCASEMENT VERSUS ABUTMENT IN PANCREATIC CANCER PATIENTS WITH MODIFIED FOLFIRINOX NEOADJUVANT CHEMOTHERAPY
JIMIN JUNG (Korea)
14:55-15:00
REAPPRAISAL OF THE PROGNOSIS OF CARCINOMA IN SITU OF THE GALLBLADDER IN SOUTH KOREA: A KOREA TUMOR REGISTRY SYSTEM BILIARY PANCREAS (KOTUS-BP) DATABASE ANALYSIS
Hee Ju SOHN (Korea)
15:00-15:05
IMPACT OF HIGH PERIOPERATIVE FLUID BALANCE ON POSTOPERATIVE OUTCOMES FOLLOWING PANCREATICODUODENECTOMY, A RETROSPECTIVE COHORT STUDY
Worakitti LAPISATEPUN (Thailand)
15:05-15:10
RISK FACTORS FOR LYMPH NODE METASTASIS AND SURVIVAL OUTCOMES IN INTRADUCTAL PAPILLARY MUCINOUS CARCINOMA (IPMC)
Go-Won CHOI (Korea)
15:10-15:15
LONG-TERM ONCOLOGIC SAFETY OF LAPAROSCOPY SURGERY FOR EARLY STAGE GALLBLADDER CANCER IN A TEN-YEAR PROSPECTIVE COHORT WITH FOLLOW-UP FOR TWENTY YEARS
Yeshong PARK (Korea)
15:15-15:20
THE IMPACT OF RESECTED-TO-ORIGINAL MIDDLE HEPATIC VEIN LENGTH PROPORTION ON POSTHEPATECTOMY LIVER FAILURE IN PERIHILAR CHOLANGIOCARCINOMA AFTER RIGHT SIDED HEPATECTOMY
Jimin SON (Korea)
15:20-15:25
THE CLINICAL IMPLICATION OF GERMLINE BRCA MUTATIONS IN PANCREATIC DUCTAL ADENOCARCINOMA BY USING BREAST CANCER PATIENT COHORT
Soo Yeun LIM (Korea)
14:50-15:30
Poster Presentation 7
[Modreator(s)] Youngil CHOI (Korea), Yun Kyung JUNG (Korea)
14:50-14:55
DYNAMIC CHANGES OF SERUM VASCULAR ENDOTHELIAL GROWTH FACTOR AFTER SURGICAL RESECTION OF HEPATOCELLULAR CARCINOMA AND ITS APPLICATION IN RECURRENCE MONITORING
Jirachaya CHOOVUTHAYAKORN (Thailand)
14:55-15:00
DEVELOPMENT OF A HYBRID PKU:FRG MOUSE MODEL FOR ENHANCED EX VIVO CELLULAR THERAPY IN PHENYLKETONURIA
Dayoung KIM (Korea)
15:00-15:05
CIRCULATING DNA AS A NON-INVASIVE DIAGNOSTIC AND PROGNOSTIC TOOL IN PANCREATIC CANCER MANAGEMENT: OUR INITIAL EXPERIENCE
Young-dong YU (Korea)
15:05-15:10
EX-VIVO GENE EDITING OF CHEMICALLY DERIVED HEPATIC PROGENITORS (CDHS) FOR TREATING MAPLE SYRUP URINE DISEASE (MSUD)
Haerin JEON (Korea)
15:30-16:30
Liver Oral Presentation 1
[Modreator(s)] Young Chul YOON (Korea), Dai Hoon HAN (Korea)
15:30-15:37
IDENTIFYING RISK FACTORS FOR DIFFUSE INTRAHEPATIC BILIARY STRICTURE IN ABO-INCOMPATIBLE LIVING DONOR LIVER TRANSPLANTATION: AN ANALYSIS OF 1,000 CASES.
Young-In YOON (Korea)
15:37-15:44
CLINICAL IMPACT OF RESECTION MARGIN IN HEPATOCELLULAR CARCINOMA
Hyojoon KIM (Korea)
15:44-15:51
THE IMPACT OF PHARMACOLOGIC GRAFT INFLOW MODULATION ON UTILIZING LEFT LOBE LIVING DONOR GRAFTS FOR ADULT LIVER TRANSPLANTATION
Dimitrios Aristotelis RAPTIS (Saudi Arabia)
15:51-15:58
DEVELOPMENT AND VALIDATION OF A LABORATORY RISK SCORE (APASL SCORE) TO PREDICT LONG-TERM SURVIVAL AFTER HEPATECTOMY FOR HEPATOCELLULAR CARCINOMA: A MULTICENTER ANALYSIS
Bai-Dong WANG (China)
15:58-16:05
OUTCOMES AND RISK FACTORS IN LIVING DONOR LIVER TRANSPLANTATION IN OLDER PATIENTS OVER 70 YEARS: A MULTICENTRIC COHORT STUDY
Mun Chae CHOI (Korea)
16:05-16:12
ADULT-TO-ADULT RIGHT LOBE GRAFT LIVING DONOR LIVER TRANSPLANTATION FOR ACUTE-ON-CHRONIC LIVER FAILURE: A SINGLE-CENTRE RETROSPECTIVE STUDY IN VIETNAM
The Duy NGUYEN (Vietnam)
16:12-16:19
HYPOTHERMIC AND NORMOTHERMIC MACHINE PERFUSION OF EXTENDED-CRITERIA DONOR LIVERS: A BAYESIAN NETWORK META-ANALYSIS OF RANDOMIZED CONTROLLED TRIALS AND MATCHED STUDIES
Minseok KANG (Korea)
16:19-16:26
PRECLINICAL STUDY FOR EVALUATING THE IMPACT OF CHOLANGIOCYTE-COATED SILICONE STENT ON PORCINE MODEL FOR BILE LEAKAGE
Sunghae PARK (Korea)
15:30-16:30
BP Oral Presentation 1
[Modreator(s)] Seoungyoon RHO (Korea), Ju Ik MOON (Korea)
15:30-15:37
ROLE OF INDOCYANINE GREEN-GUIDED SENTINEL LYMPH NODE BIOPSY IN MANAGEMENT OF GALLBLADDER CARCINOMA – PRELIMINARY STUDY RESULTS
Shiva SHIVA (India)
15:37-15:44
MULTIMODAL INTEGRATION OF LIQUID BIOPSY AND RADIOLOGY FOR NONINVASIVE DIAGNOSIS OF GALLBLADDER CANCER AND BENIGN DISORDERS: A MULTI-CENTER, PROSPECTIVE STUDY
Yuhao ZHAO (China)
15:44-15:51
HOW DO WE ASESS THE OPERATIVE RISK OF HEPATOBILIARY-PANCREAS SURGERY IN ELDERLY PATIENTS: RETROSPECTIVE ANALYSIS USING COMPREHENSIVE FRAILTY ASESSMENT
Mirang LEE (Korea)
15:51-15:58
CLINICAL COURSE OF SPLENIC INFARCTION AFTER SPLEEN PRESERVING DISTAL PANCREATECTOMY
Hochang CHAE (Korea)
15:58-16:05
LYMPH NODE METASTATIC PATTERNS AND APPROPRIATE EXTENT OF DISSECTION IN LEFT-SIDED PANCREATIC CANCER
Inhyuck LEE (Korea)
16:05-16:12
DEVELOPING A NOVEL PANCREATIC ADENOCARCINOMA ORGANOID MODEL USING CRISPR-CAS9 EDITED WITH HUMAN PANCREATIC ORGANOIDS
Eden Demere AMARE (Korea)
16:12-16:19
PROGNOSTIC IMPLICATIONS OF INTRACYSTIC PAPILLARY NEOPLASM IN INVASIVE GALLBLADDER CANCER
Su Min JEON (Korea)
16:19-16:26
MINIMALLY INVASIVE SPLEEN-PRESERVING DISTAL PANCREATECTOMY: SPLENIC VESSEL-PRESERVING PROCEDURE IS A “DOUBLE-EDGED SWORD” IN LEFT-SIDED PORTAL HYPERTENSION
Yusuke WATANABE (Japan)
15:30-16:30
Liver Oral Presentation 2
[Modreator(s)] Je Ho RYU (Korea), Alfred Wei Chieh KOW (Singapore)
15:30-15:37
SUPERIOR PROGNOSTIC PERFORMANCE OF THE AFP MODEL OVER MILAN CRITERIA FOLLOWING HEPATIC RESECTION FOR HEPATOCELLULAR CARCINOMA: A MULTI-INSTITUTIONAL ANALYSIS
Chao LI (China)
15:37-15:44
IMPROVED LONG-TERM SURVIVAL OUTCOMES AFTER HEPATECTOMY FOR HEPATOCELLULAR CARCINOMA: A COMPARATIVE ANALYSIS OF TWO FIVE-YEAR PHASES FROM CHINA
Chao LI (China)
15:44-15:51
ROLE OF HEPATOBILIARY SCINTIGRAPHY IN PREDICTING POST-HEPATECTOMY LIVER FAILURE: A SINGLE-CENTER COHORT STUDY
Jeong-Moo LEE (Korea)
15:51-15:58
TRANSFISSURAL VERSUS HILAR APPROACH IN LAPAROSCOPIC SEGMENT 8 RESECTION: STRATEGIC ADAPTATION TO RIGHT ANTERIOR GLISSONEAN ANATOMY
Kwangpyo HONG (Korea)
15:58-16:05
DEFINING CLINICAL FACTORS PREDICTING A PATIENT’S LIVER REGENERATION VOLUME AFTER RIGHT HEMIHEPATECTOMY
Jiwon YU (Korea)
16:05-16:12
HEPATECTOMY FOR COLORECTAL LIVER METASTASES IN PATIENTS WHO PROGRESSED AFTER PREOPERATIVE CHEMOTHERAPYHEPATECTOMY FOR COLORECTAL LIVER METASTASES IN PATIENTS WHO PROGRESSED AFTER PREOPERATIVE CHEMOTHERAPY
Yu SAWADA (Japan)
16:12-16:19
IMPACT OF RADIATION THERAPY ON BILIARY COMPLICATIONS IN LIVER TRANSPLANTA HEPATOCELLULAR CARCINTION RECIPIENTS WITHOMA: A PROPENSITY SCORE-MATCHED ANALYSIS
Min-Ha CHOI (Korea)
16:19-16:26
FEASIBILITY OF SIMULTANEOUS SPLENECTOMY IN ABO INCOMPATIBLE LIVING DONOR LIVER TRANSPLANTATION WITH SMALL-FOR-SIZE GRAFT
JaRyung HAN (Korea)
15:30-16:30
Liver Oral Presentation 3
[Modreator(s)] Hae Won LEE (Korea), Gyu Seong CHOI (Korea)
15:30-15:37
INNOVATIVE ARTIFICIAL INTELLIGENCE AND MACHINE LEARNING BASED SPATIAL COMPUTING AR NAVIGATION FOR OPEN, LAP, AND ROBOTIC HEPATECTOMY
Maki SUGIMOTO (Japan)
15:37-15:44
PREDICTIVE VALUE OF THE BODY WEIGHT-ADJUSTED FUTURE LIVER REMNANT-TO-SPLEEN VOLUME RATIO IN POST-HEPATECTOMY LIVER FAILURE FOLLOWING HEMI-HEPATECTOMY
Hyung Hwan MOON (Korea)
15:44-15:51
SHIFTING PARADIGMS: MAGNETIC RESONANCE SPECTROSCOPY AS A NON-INVASIVE ALTERNATIVE TO LIVER NEEDLE BIOPSY IN FATTY LIVER DONOR EVALUATION
Jiyoung KIM (Korea)
15:51-15:58
SURROGACY OF RECURRENCE-FREE SURVIVAL FOR OVERALL SURVIVAL IN HEPATOCELLULAR CARCINOMA
Keisuke OKURA (Japan)
15:58-16:05
SURVIVAL BENEFITS OF CURATIVE APPROACHES FOR HEPATOCELLULAR CARCINOMA WITH HEPATIC VEIN INVASION: A NATIONWIDE COHORT STUDY
Sehyeon YU (Korea)
16:05-16:12
MICROWAVE ABLATION VERSUS LIVER RESECTION FOR EARLY HEPATOCELLULAR CARCINOMA IN PATIENTS WITH BORDERLINE LIVER FUNCTION (MAVERL STUDY)
Charing CHONG (Hong Kong, China)
16:12-16:19
APPLICATION OF AI-BASED VOLUMETRY IN LIVER TRANSPLANTATION: ENHANCING ACCURACY AND SPEED IN CLINICAL PRACTICE
Yu SAWADA (Korea)
16:19-16:26
BELIEFS ABOUT ANATOMICAL LIVER RESECTION: DOES ANATOMICAL LIVER RESECTION ALWAYS ENSURE ADEQUATE SURGICAL MARGINS?
Seung Yeon LIM (Korea)
15:30-16:30
BP Oral Presentation 2
[Modreator(s)] Incheon KANG (Korea), Hyeong Min PARK (Korea)
15:30-15:37
OPTIMAL NEOADJUVANT THERAPY STRATEGIES FOR PATHOLOGIC COMPLETE REMISSION AND ITS PROGNOSTIC IMPLICATION IN PANCREATIC CANCER
Hyeong Seok KIM (Korea)
15:37-15:44
PREOPERATIVE RISK STRATIFICATION IN HILAR CHOLANGIOCARCINOMA USING A NOVEL DECISION TREE MODEL
Yuze YANG (China)
15:44-15:51
RADIOMICS CLUSTERING OF F-18 FDG PET/CT FOR THE PREDICTION OF PROGNOSIS IN INTRAHEPATIC CHOLANGIOCARCINOMA
Keun Soo AHN (Korea)
15:51-15:58
MORTALITY FOLLOWING SPLENECTOMY: ADVANCED INSIGHTS FROM NATIONAL COHORT ANALYSIS
Jae Hyun HAN (Korea)
15:58-16:05
A DESCRIPTIVE ANALYSIS OF THE NATURAL CLINICAL COURSE OF PDAC PRIMARILY TREATED WITH MFOLFIRINOX: INITIAL RESECTABILITY DOES NOT CORRELATE WITH PROGNOSIS
Jimin SON (Korea)
16:05-16:12
COMPARISON OF REDUCED-PORT TOTALLY ROBOTIC PANCREATICODUODENECTOMY WITH CONVENTIONAL TOTALLY ROBOTIC AND LAPAROSCOPIC PANCREATICODUODENECTOMY
Hyelim JOO (Korea)
16:12-16:19
AUTOMATED IDENTIFICATION OF CRITICAL STRUCTURES IN LAPAROSCOPIC CHOLECYSTECTOMY WITH ARTIFICIAL INTELLIGENCE
Jae Hyun KWON (Korea)
16:19-16:26
MULTIDISCIPLINARY TREATMENT FOR ADVANCED PERIHILAR CHOLANGIOCARCINOMA
YASUHIRO YABUSHITA (Japan)
15:30-16:30
BP Oral Presentation 3
[Modreator(s)] Jin Ho LEE (Korea), Junchul CHUNG (Korea)
15:30-15:37
EVALUATION OF CIRCULATING TUMOR DNA IN PORTAL VEIN BLOOD AS A BIOMARKER FOR EARLY RECURRENCE OF PANCREATIC CANCER
Lingdi YIN (China)
15:37-15:44
SIGNIFICANCE OF CONVERSION SURGERY FOR UNRESECTABLE BILIARY TRACT CANCER
Ryusei MATSUYAMA (Japan)
15:44-15:51
THE EFFECT OF PREOPERATIVE RADIOTHERAPY IN THE RESECTABLE PANCREATIC CANCER : A PROSPECTIVE SINGLE CENTER PILOT STUDY
Seung Soo HONG (Korea)
15:51-15:58
PROPOSAL OF A NOVEL NODAL STAGING SYSTEM FOR RESECTED PANCREATIC CANCER AFTER NEOADJUVANT THERAPY
Aram SHIN (Korea)
15:58-16:05
REVISITING THE SURGICAL STRATEGY OF T1B GALLBLADDER CANCER: A KOREA TUMOR REGISTRY SYSTEM BILIARY PANCREAS (KOTUS-BP) DATABASE ANALYSIS
Hee Ju SOHN (Korea)
16:05-16:12
ROLE OF ADJUVANT CHEMOTHERAPY AFTER HEPATIC RESECTION FOR PATIENTS WITH INVASIVE INTRADUCTAL PAPILLARY NEOPLASM OF THE BILE DUCT (IPNB)
Pun PUGKHEM (Thailand)
16:12-16:19
NEW PATHOLOGICAL RESPONSE SYSTEM; SHRINKAGE PATTERNS FOR RESECTABLE/ BORDERLINE RESECTABLE PANCREATIC CANCERS.
Hidetaka MIYAZAKI (Japan)
16:19-16:26
OPTIMAL TREATMENT STRATEGY IN PATIENTS WITH SUBOPTIMAL RESPONSE WHO UNDERWENT INDUCTION CHEMOTHERAPY FOR LOCALLY ADVANCED PANCREATIC CANCER (LAPC): TO RESECT OR CONTINUE CHEMOTHERAPY?
Hye-Sol JUNG (Korea)
16:30-16:40
Break
16:40-18:10
Liver Symposium 2 - Multidisciplinary approaches for HCC
[Modreator(s)] Dong-Sik KIM (Korea), Yuta ABE (Japan)
[Panel(s)] Jinhong JUNG (Korea), Min Woo LEE (Korea), Tharatip SRISUK (Thailand)
16:40-16:50
Primary locoregional treatment prior to resection for resectable HCC
Hye Won LEE (Korea)
16:50-17:10
Case Discussion 1: a case with huge HCC, a small HCC case adjacent to major vessel (+ voting)
JaRyung HAN (Korea)
17:10-17:20
Conversion surgery after immune/chemotherapy for initially unresectable HCC
Yuri CHO (Korea)
17:20-17:40
Case Discussion 2: a successful case & a case with complication (+/- voting)
Young-in YOON (Korea)
17:40-17:50
Adjuvant therapy after resection
Eun Ju CHO (Korea)
17:50-18:10
Case Discussion 3: an early HCC & an advanced HCC (+ voting: adjuvant immunotherapy or radiation therapy)
Sung Hwan LEE (Korea)
16:40-18:10
BP Symposium 2 - HBP diseases mimicking cancers
[Modreator(s)] Sae Byeol CHOI (Korea), Nagesh GOWDA (India)
16:40-17:00
Liver - pseudotumor
Jae Hyun HAN (Korea)
17:00-17:20
Biliary tract - stricture
Hee Joon KIM (Korea)
17:20-17:40
GB - xanthogranulomatous cholecystitis
Vikram CHAUDHARI (India)
17:40-18:00
Pancreas - IgG4 pancreatitis
Sang Hyub LEE (Korea)
18:00-18:10
Discussion
16:40-18:10
HBP Symposium 1 - Artificial intelligence in HBP field
[Modreator(s)] Jin Hong LIM (Korea), Kwan Woo KIM (Korea)
16:40-17:00
Automated segmentation and volumetry
Dooho LEE (Korea)
17:00-17:20
Risk prediction platform
In Woong HAN (Korea)
17:20-17:40
Surgical video annotation
Sung Hyun KIM (Korea)
17:40-18:00
Artificial intelligence for intraoperative guidance
Takuto YOSHIDA (Japan)
18:00-18:10
Discussion